About Technology Issues FAQ

Links

First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study

First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.